ABEONA THERAPEUTICS INC. Amortization of Intangible Assets
ABEONA THERAPEUTICS INC. (ABEO) reported Amortization of Intangible Assets of $29.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2022-05-13
- ABEONA THERAPEUTICS INC. amortization of intangible assets for the quarter ending 2022-03-31 was $29.00K, a 0.00% change year-over-year.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for the quarter ending 2021-12-31 was $29.00K.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for the quarter ending 2021-09-30 was $29.00K, a 32.56% decline year-over-year.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for the quarter ending 2021-06-30 was $29.00K, a 34.09% decline year-over-year.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for fiscal 2021 was $116.00K, a 91.71% decline from fiscal 2020.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for fiscal 2020 was $1.40M, a 73.08% decline from fiscal 2019.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for fiscal 2019 was $5.20M, a 333.33% increase from fiscal 2018.
- ABEONA THERAPEUTICS INC. amortization of intangible assets for fiscal 2018 was $1.20M, a 140.00% increase from fiscal 2017.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | $29.00K 10-Q · filed 2022-05-13 | $58.00K derived: sum of 2 quarters · filed 2022-05-13 | $87.00K derived: sum of 3 quarters · filed 2022-05-13 | $116.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2021-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $58.00K derived: sum of 2 quarters · filed 2022-03-31 | $87.00K derived: sum of 3 quarters · filed 2022-03-31 | $116.00K 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | $29.00K 10-Q · filed 2021-11-15 | $58.00K derived: sum of 2 quarters · filed 2021-11-15 | $87.00K 10-Q · filed 2021-11-15 | $87.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2021-06-30 | $29.00K 10-Q · filed 2021-07-28 | $58.00K 10-Q · filed 2021-07-28 | $58.00K derived: sum of 3 quarters · filed 2022-05-13 | $101.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2021-03-31 | $29.00K 10-Q · filed 2022-05-13 | $29.00K derived: sum of 2 quarters · filed 2022-05-13 | $72.00K derived: sum of 3 quarters · filed 2022-05-13 | $116.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $43.00K derived: sum of 2 quarters · filed 2022-03-31 | $87.00K derived: sum of 3 quarters · filed 2022-03-31 | $1.40M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $43.00K 10-Q · filed 2021-11-15 | $87.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.40M 10-Q · filed 2021-11-15 | $1.38M 10-Q · filed 2020-11-09 | $2.66M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $44.00K 10-Q · filed 2021-07-28 | $1.30M 10-Q · filed 2021-07-28 | $1.34M 10-Q · filed 2020-08-10 | $2.61M derived: sum of 3 quarters · filed 2021-07-28 | $3.91M derived: sum of 4 quarters · filed 2021-07-28 | |||
| 2020-03-31 | $1.30M 10-Q · filed 2021-05-17 | $1.29M 10-Q · filed 2020-05-06 | $2.57M derived: sum of 2 quarters · filed 2021-05-17 | $3.86M derived: sum of 3 quarters · filed 2021-05-17 | $5.16M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $2.56M derived: sum of 2 quarters · filed 2021-03-24 | $3.85M derived: sum of 3 quarters · filed 2021-03-24 | $5.20M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | $1.29M 10-Q · filed 2020-11-09 | $2.59M derived: sum of 2 quarters · filed 2020-11-09 | $3.93M 10-Q · filed 2020-11-09 | $4.87M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $1.29M 10-Q · filed 2020-08-10 | $2.64M 10-Q · filed 2020-08-10 | $3.58M derived: sum of 3 quarters · filed 2020-08-10 | $3.67M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $1.34M 10-Q · filed 2020-05-06 | $2.29M derived: sum of 2 quarters · filed 2020-05-06 | $2.37M derived: sum of 3 quarters · filed 2020-05-06 | $2.46M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.03M derived: sum of 2 quarters · filed 2020-03-16 | $1.11M derived: sum of 3 quarters · filed 2020-03-16 | $1.20M 10-K · filed 2020-03-16 | $1.19M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $87.00K 10-Q · filed 2019-11-12 | $174.00K derived: sum of 2 quarters · filed 2019-11-12 | $260.00K 10-Q · filed 2019-11-12 | $313.00K derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | $87.00K 10-Q · filed 2019-08-09 | $174.00K 10-Q · filed 2019-08-09 | $226.00K derived: sum of 3 quarters · filed 2020-03-16 | $313.00K derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-03-31 | $87.00K 10-Q · filed 2019-05-10 | $139.00K derived: sum of 2 quarters · filed 2020-03-16 | $226.00K derived: sum of 3 quarters · filed 2020-03-16 | $384.00K derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $139.00K derived: sum of 2 quarters · filed 2020-03-16 | $297.00K derived: sum of 3 quarters · filed 2020-03-16 | $500.00K 10-K · filed 2020-03-16 | $534.00K 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $87.00K 10-Q · filed 2018-11-09 | $245.00K derived: sum of 2 quarters · filed 2018-11-09 | $448.00K 10-Q · filed 2018-11-09 | $834.00K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $158.00K 10-Q · filed 2018-08-09 | $361.00K 10-Q · filed 2018-08-09 | $747.00K derived: sum of 3 quarters · filed 2019-03-18 | $893.00K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $203.00K 10-Q · filed 2018-05-10 | $589.00K derived: sum of 2 quarters · filed 2019-03-18 | $735.00K derived: sum of 3 quarters · filed 2019-03-18 | $881.00K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $532.00K derived: sum of 2 quarters · filed 2019-03-18 | $678.00K derived: sum of 3 quarters · filed 2019-03-18 | $677.00K 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $146.00K 10-Q · filed 2017-11-14 | $183.00K 10-Q · filed 2016-11-14 | $292.00K derived: sum of 2 quarters · filed 2017-11-14 | $291.00K 10-Q · filed 2017-11-14 | $474.00K 10-Q · filed 2016-11-14 | $583.00K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $146.00K 10-Q · filed 2017-08-14 | $291.00K 10-Q · filed 2017-08-14 | $437.00K derived: sum of 3 quarters · filed 2017-08-14 | $582.00K derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $145.00K 10-Q · filed 2017-05-15 | $291.00K derived: sum of 2 quarters · filed 2017-05-15 | $436.00K derived: sum of 3 quarters · filed 2017-05-15 | $552.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $291.00K derived: sum of 2 quarters · filed 2017-03-30 | $407.00K derived: sum of 3 quarters · filed 2017-03-30 | $538.00K 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $145.00K 10-Q · filed 2016-11-14 | $261.00K derived: sum of 2 quarters · filed 2016-11-14 | $392.00K 10-Q · filed 2016-11-14 | $386.00K derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $116.00K 10-Q · filed 2016-08-15 | $232.00K 10-Q · filed 2016-08-15 | $241.00K derived: sum of 3 quarters · filed 2016-08-15 | $241.00K derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $116.00K 10-Q · filed 2016-05-16 | $125.00K derived: sum of 2 quarters · filed 2016-05-16 | $125.00K derived: sum of 3 quarters · filed 2016-05-16 | $125.00K derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $9.00K derived: sum of 2 quarters · filed 2016-03-30 | $9.00K derived: sum of 3 quarters · filed 2016-03-30 | $9.00K 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | |||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 | |||||||
| 2012-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $302.00K derived: sum of 2 quarters · filed 2013-03-20 | $313.00K derived: sum of 3 quarters · filed 2013-03-20 | $362.00K 10-K · filed 2013-03-20 | ||||
| 2012-09-30 | $11.00K 10-Q · filed 2012-11-14 | $22.00K derived: sum of 2 quarters · filed 2012-11-14 | $71.00K 10-Q · filed 2012-11-14 | $124.00K derived: sum of 4 quarters · filed 2013-03-20 | ||||
| 2012-06-30 | $11.00K 10-Q · filed 2012-08-14 | $60.00K 10-Q · filed 2012-08-14 | $113.00K derived: sum of 3 quarters · filed 2013-03-20 | $166.00K derived: sum of 4 quarters · filed 2013-03-20 | ||||
| 2012-03-31 | $49.00K derived: 10-K 12 month − 3 quarters · filed 2013-03-20 | $102.00K derived: sum of 2 quarters · filed 2013-03-20 | $155.00K derived: sum of 3 quarters · filed 2013-03-20 | $208.00K derived: sum of 4 quarters · filed 2013-03-20 | ||||
| 2011-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $106.00K derived: sum of 2 quarters · filed 2013-03-20 | $159.00K derived: sum of 3 quarters · filed 2013-03-20 | $212.00K 10-K · filed 2013-03-20 | ||||
| 2011-09-30 | $53.00K 10-Q · filed 2012-11-14 | $106.00K derived: sum of 2 quarters · filed 2012-11-14 | $159.00K 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $53.00K 10-Q · filed 2012-08-14 | $106.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |